| scholarly article | Q13442814 |
| P356 | DOI | 10.1211/JPP.61.07.0001 |
| P698 | PubMed publication ID | 19589224 |
| P2093 | author name string | Feng He | |
| Sheng Fu | |||
| Rongbiao Pi | |||
| Minzhong Ye | |||
| P2860 | cites work | The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 |
| Age-related differences in NFkappaB translocation and Bcl-2/Bax ratio caused by TNFalpha and Abeta42 promote survival in middle-age neurons and death in old neurons | Q28565715 | ||
| Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease | Q33265122 | ||
| Screening of acetylcholinesterase inhibitors in natural extracts by CE with electrophoretically mediated microanalysis technique | Q33265865 | ||
| Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine | Q34594086 | ||
| Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice | Q34679595 | ||
| The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development | Q35153875 | ||
| Mechanisms of ischemic brain injury | Q35647414 | ||
| Human MDR1 and MRP1 recognize berberine as their transport substrate | Q40184878 | ||
| Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease Abeta secretion | Q40204649 | ||
| A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species. | Q40569643 | ||
| In vitro antiplasmodial activity of antimalarial medicinal plants used in Vietnamese traditional medicine | Q41915928 | ||
| Monoamine oxidase inhibitors from rhizoma of Coptis chinensis | Q43554947 | ||
| Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by a Coptidis Rhizoma extract and protoberberine alkaloids | Q44266226 | ||
| Effects of berberine on potassium currents in acutely isolated CA1 pyramidal neurons of rat hippocampus | Q44744808 | ||
| Coptidis Rhizoma: protective effects against peroxynitrite-induced oxidative damage and elucidation of its active components | Q44852668 | ||
| Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: interaction with drugs acting at 5-HT receptors | Q45046434 | ||
| Antiradical and antioxidant activities of alkaloids isolated from Mahonia aquifolium. Structural aspects. | Q45052402 | ||
| Isolation and identification of urinary metabolites of berberine in rats and humans | Q46429115 | ||
| On the mechanism of antidepressant-like action of berberine chloride | Q46514147 | ||
| Kinetic difference of berberine between hippocampus and plasma in rat after intravenous administration of Coptidis rhizoma extract | Q46582470 | ||
| Simultaneous determination of berberine and palmatine in rat plasma by HPLC-ESI-MS after oral administration of traditional Chinese medicinal preparation Huang-Lian-Jie-Du decoction and the pharmacokinetic application of the method | Q46808969 | ||
| Coptidis Rhizoma attenuates repeated nicotine-induced behavioural sensitization in the rat. | Q46870975 | ||
| Simultaneous quantification of three alkaloids of Coptidis Rhizoma in rat urine by high-performance liquid chromatography: application to pharmacokinetic study | Q46984576 | ||
| Berberry extract reduces neuronal damage and N-Methyl-D-aspartate receptor 1 immunoreactivity in the gerbil hippocampus after transient forebrain ischemia | Q48593543 | ||
| Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry | Q51136374 | ||
| Acetylcholinesterase inhibitors from Stephania venosa tuber. | Q55041868 | ||
| 8-hydroxydihydrochelerythrine and 8-hydroxydihydrosanguinarine with a potent acetylcholinesterase inhibitory activity from Chelidonium majus L | Q79319894 | ||
| P433 | issue | 7 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| P304 | page(s) | 831-837 | |
| P577 | publication date | 2009-07-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Journal of Pharmacy and Pharmacology | Q10532762 |
| P1476 | title | Neuropharmacological and pharmacokinetic properties of berberine: a review of recent research | |
| P478 | volume | 61 |
| Q28539687 | Acacetin inhibits glutamate release and prevents kainic acid-induced neurotoxicity in rats |
| Q28535072 | An effective solution to discover synergistic drugs for anti-cerebral ischemia from traditional Chinese medicinal formulae |
| Q53171809 | Anti-atherosclerotic action of Ger-Gen-Chyn-Lian-Tang and AMPK-dependent lipid lowering effect in hepatocytes |
| Q58816542 | Anti-inflammatory treatment in patients after percutaneous coronary intervention: another potential use for berberine? |
| Q89537434 | Berberine Inhibits Growth of Liver Cancer Cells by Suppressing Glutamine Uptake |
| Q33954876 | Berberine Inhibits Human Hepatoma Cell Invasion without Cytotoxicity in Healthy Hepatocytes |
| Q28533983 | Berberine Inhibits the Release of Glutamate in Nerve Terminals from Rat Cerebral Cortex |
| Q90355979 | Berberine Protects Secondary Injury in Mice with Traumatic Brain Injury Through Anti-oxidative and Anti-inflammatory Modulation |
| Q38326750 | Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies |
| Q33819623 | Berberine attenuates convulsing behavior and extracellular glutamate and aspartate changes in 4-aminopyridine treated rats |
| Q50746082 | Berberine chloride improved synaptic plasticity in STZ induced diabetic rats. |
| Q49938330 | Berberine confers neuroprotection in coping with focal cerebral ischemia by targeting inflammatory cytokines. |
| Q42315660 | Berberine exerts an anti-inflammatory role in ocular Behcet's disease. |
| Q37914665 | Berberine: A Potential Multipotent Natural Product to Combat Alzheimer’s Disease |
| Q88419158 | Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential |
| Q38221853 | Comparison of Two Old Phytochemicals versus Two Newly Researched Plant-Derived Compounds: Potential for Brain and Other Relevant Ailments |
| Q34094808 | Decrease in the production of beta-amyloid by berberine inhibition of the expression of beta-secretase in HEK293 cells |
| Q38768934 | Development and evaluation of vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of berberine as an anticancer nanopharmaceutical |
| Q64235002 | Effect of berberine chloride on caspase-3 dependent apoptosis and antioxidant capacity in the hippocampus of the chronic cerebral hypoperfusion rat model |
| Q33839604 | Evaluation of diuretic activity of alcoholic extract of roots of cissampelos pareira in albino rats |
| Q34108379 | Evalution of antiurolithic activity of alcoholic extract of roots of cissampelos pareira in albino rats |
| Q100633960 | Exposure to the natural alkaloid Berberine affects cardiovascular system morphogenesis and functionality during zebrafish development |
| Q48375154 | Hypoxia-inducible factor 1 mediates the anti-apoptosis of berberine in neurons during hypoxia/ischemia |
| Q38156718 | Learning from berberine: Treating chronic diseases through multiple targets |
| Q42710806 | Mechanism study of goldenseal-associated DNA damage |
| Q28542840 | Mitochondria and NMDA receptor-dependent toxicity of berberine sensitizes neurons to glutamate and rotenone injury |
| Q58915075 | Molecular Basis of Inhibitory Activities of Berberine against Pathogenic Enzymes in Alzheimer's Disease |
| Q37729182 | Natural compounds from traditional medicinal herbs in the treatment of cerebral ischemia/reperfusion injury |
| Q26749019 | Natural polyphenols: Influence on membrane transporters |
| Q47700141 | Neuroprotective effect of berberine chloride on cognitive impairment and hippocampal damage in experimental model of vascular dementia |
| Q36466144 | Pharmacokinetics and Relative Bioavailability of Flavonoids between Two Dosage Forms of Gegen-Qinlian-Tang in Rats. |
| Q38648635 | Pharmacological effects of berberine and its derivatives: a patent update |
| Q93204960 | Pharmacological effects of berberine on mood disorders |
| Q34280202 | Physicochemical Characterization of Berberine Chloride: A Perspective in the Development of a Solution Dosage Form for Oral Delivery |
| Q28581700 | Protective Effects of Berberine in an Experimental Rat Osteoarthritis Model |
| Q57022275 | Self-nanoemulsifying system improves oral absorption and enhances anti-acute myeloid leukemia activity of berberine |
| Q42720448 | Structure–activity studies of some berberine analogs as inhibitors of Toxoplasma gondii |
| Q50850457 | Synergistic inhibition on acetylcholinesterase by the combination of berberine and palmatine originally isolated from Chinese medicinal herbs |
| Q39177350 | The metabolism of berberine and its contribution to the pharmacological effects |
| Q37355794 | Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS. |
Search more.